Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 218,250 | 156,413 | 406,555 | 159,395 | 163,353 |
| Cost of Goods | 3,840 | 5,377 | 9,522 | 2,187 | 2,798 |
| Gross Profit | 214,410 | 151,036 | 397,033 | 157,208 | 160,555 |
| Operating Expenses | 116,785 | 853,011 | 137,170 | 127,804 | 131,567 |
| Operating Income | 98,465 | -701,598 | 260,385 | 29,591 | 29,786 |
| Interest Expense | 21,712 | 19,779 | 14,135 | 19,661 | 21,582 |
| Other Income | 2,721 | 569 | 1,767 | 2,200 | -1,718 |
| Pre-tax Income | 79,474 | -720,808 | 248,017 | 12,130 | 6,486 |
| Income Tax | 1,079 | 1,004 | 2,172 | -769 | 1,401 |
| Net Income Continuous | 78,395 | -721,812 | 245,845 | 12,899 | 5,085 |
| Net Income | $78,395 | $-721,812 | $245,845 | $12,899 | $5,085 |
| EPS Basic Total Ops | 0.31 | -2.98 | 1.18 | 0.06 | 0.02 |
| EPS Basic Continuous Ops | 0.31 | -2.98 | 1.17 | 0.06 | 0.02 |
| EPS Diluted Total Ops | 0.30 | -2.98 | 1.13 | 0.06 | 0.02 |
| EPS Diluted Continuous Ops | 0.30 | -2.98 | 1.13 | 0.06 | 0.02 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.03 | 1.12 | 0.06 | 0.15 |
| EBITDA(a) | $98,764 | $-700,137 | $259,688 | $28,216 | $29,424 |